ML290 is a biased allosteric agonist at the relaxin receptor RXFP1Martina Kočan, Jingbo Xiao, Juan Marugán et al.|Scientific Reports|2017Cited by 62
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOateChao Wang, Chrishan S. Samuel|Frontiers in Pharmacology|2016Cited by 40